KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biolife Solutions (BLFS) EBT (2016 - 2025)

Biolife Solutions (BLFS) has disclosed EBT for 16 consecutive years, with $3.4 million as the latest value for Q4 2025.

  • Quarterly EBT rose 616.84% to $3.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$12.1 million through Dec 2025, down 36.93% year-over-year, with the annual reading at -$12.1 million for FY2025, 36.93% down from the prior year.
  • EBT for Q4 2025 was $3.4 million at Biolife Solutions, up from $703000.0 in the prior quarter.
  • The five-year high for EBT was $90.7 million in Q4 2022, with the low at -$76.6 million in Q2 2022.
  • Average EBT over 5 years is -$3.6 million, with a median of -$4.8 million recorded in 2021.
  • The sharpest move saw EBT plummeted 1538.52% in 2022, then skyrocketed 616.84% in 2025.
  • Over 5 years, EBT stood at -$18.3 million in 2021, then surged by 595.03% to $90.7 million in 2022, then crashed by 80.58% to $17.6 million in 2023, then tumbled by 97.34% to $469000.0 in 2024, then surged by 616.84% to $3.4 million in 2025.
  • According to Business Quant data, EBT over the past three periods came in at $3.4 million, $703000.0, and -$15.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.